ORTOLAN, AUGUSTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.155
AS - Asia 2.223
EU - Europa 1.436
AF - Africa 582
SA - Sud America 498
OC - Oceania 59
Continente sconosciuto - Info sul continente non disponibili 35
AN - Antartide 1
Totale 8.989
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.854
SG - Singapore 833
CN - Cina 347
IT - Italia 316
HK - Hong Kong 293
BR - Brasile 285
DE - Germania 161
VN - Vietnam 154
FI - Finlandia 77
PL - Polonia 77
FR - Francia 72
SE - Svezia 64
GB - Regno Unito 60
RU - Federazione Russa 56
BJ - Benin 53
NL - Olanda 53
IN - India 52
AR - Argentina 40
MX - Messico 35
IE - Irlanda 34
TR - Turchia 30
CA - Canada 29
ZA - Sudafrica 29
IQ - Iraq 28
AT - Austria 27
ES - Italia 27
RO - Romania 26
UY - Uruguay 26
UA - Ucraina 25
AE - Emirati Arabi Uniti 24
CO - Colombia 24
EC - Ecuador 23
AU - Australia 22
BA - Bosnia-Erzegovina 22
ID - Indonesia 22
JP - Giappone 22
AL - Albania 21
PA - Panama 21
TW - Taiwan 21
CL - Cile 20
CZ - Repubblica Ceca 20
PE - Perù 20
PS - Palestinian Territory 20
PT - Portogallo 20
EE - Estonia 19
GM - Gambi 19
IL - Israele 19
IR - Iran 19
JM - Giamaica 19
NP - Nepal 19
PY - Paraguay 19
SI - Slovenia 19
CM - Camerun 18
CR - Costa Rica 18
CW - ???statistics.table.value.countryCode.CW??? 18
GA - Gabon 18
HU - Ungheria 18
SA - Arabia Saudita 18
TJ - Tagikistan 18
GT - Guatemala 17
KH - Cambogia 17
KZ - Kazakistan 17
MA - Marocco 17
MG - Madagascar 17
MK - Macedonia 17
NG - Nigeria 17
SO - Somalia 17
UZ - Uzbekistan 17
AZ - Azerbaigian 16
BZ - Belize 16
CY - Cipro 16
EG - Egitto 16
HR - Croazia 16
JO - Giordania 16
PH - Filippine 16
PR - Porto Rico 16
VE - Venezuela 16
XK - ???statistics.table.value.countryCode.XK??? 16
BY - Bielorussia 15
CD - Congo 15
CV - Capo Verde 15
GE - Georgia 15
GF - Guiana Francese 15
ME - Montenegro 15
MY - Malesia 15
SN - Senegal 15
TZ - Tanzania 15
DJ - Gibuti 14
KR - Corea 14
LY - Libia 14
NO - Norvegia 14
TH - Thailandia 14
TT - Trinidad e Tobago 14
ZW - Zimbabwe 14
BS - Bahamas 13
BW - Botswana 13
CG - Congo 13
CH - Svizzera 13
DZ - Algeria 13
GR - Grecia 13
Totale 8.387
Salva come PNG Salva come JPEG
Città #
Fairfield 609
Ashburn 526
Singapore 462
Chandler 326
Hong Kong 271
Woodbridge 251
Cambridge 233
Houston 212
Seattle 199
Beijing 134
Ann Arbor 133
Wilmington 132
Boardman 86
Santa Clara 79
Ho Chi Minh City 62
San Diego 60
Munich 59
Princeton 56
Padova 55
Los Angeles 54
Cotonou 52
Medford 52
Bytom 45
Des Moines 36
Milan 35
Helsinki 34
Rome 34
Roxbury 30
Chicago 28
Hanoi 28
New York 27
São Paulo 27
Dublin 25
Montevideo 22
Nanjing 21
Vienna 21
London 20
Amsterdam 19
Panama City 19
Guangzhou 18
Libreville 18
Falkenstein 17
Willemstad 17
Dushanbe 16
Lappeenranta 16
Lima 16
Baghdad 15
Baku 15
Dakar 15
Kingston 15
Phnom Penh 15
Verona 15
Amman 14
Chennai 14
Dallas 14
Podgorica 14
Praia 14
Tashkent 14
Frankfurt am Main 13
Hefei 13
Nassau 13
Nouakchott 13
San José 13
Ulan Bator 13
Antananarivo 12
Buffalo 12
Harare 12
Hargeisa 12
Kigali 12
Abidjan 11
Atlanta 11
Brasília 11
Conakry 11
Dubai 11
Havana 11
Kinshasa 11
Ljubljana 11
Lusaka 11
Tallinn 11
Turku 11
Zagreb 11
Boston 10
Castries 10
Cayenne 10
Dar es Salaam 10
Lisbon 10
Luanda 10
Nairobi 10
Niamey 10
Riga 10
Tbilisi 10
Tokyo 10
Accra 9
Bamako 9
Banjul 9
Belize City 9
Bishkek 9
Bogotá 9
Brazzaville 9
Da Nang 9
Totale 5.318
Salva come PNG Salva come JPEG
Nome #
Serological Biomarkers in Early Axial Spondyloarthritis During 24-Months Follow Up (Italian Arm of Space Study) 210
Atherosclerosis progression in psoriatic arthritis patients despite the treatment with tumor necrosis factor-alpha blockers: A two-year prospective observational study. 200
SARS-CoV-2 infection in patients with autoimmune rheumatic diseases in northeast Italy: A cross-sectional study on 916 patients 198
Erosive hand osteoarthritis: latest findings and outlook 192
Serological markers of erosive hand osteoarthritis 189
A recently developed MRI scoring system for hand osteoarthritis: its application in a clinical setting 187
Predictors of response and drug survival in ankylosing spondylitis patients treated with infliximab 185
The controversial relationship between osteoarthritis and osteoporosis: an update on hand subtypes 178
Lengthening the time intervals between doses of biological agents in psoriatic arthritis patients: A single-center retrospective study 171
Influence of tumor necrosis factor α inhibitors on testicular function and semen in spondyloarthritis patients 167
Metabolic syndrome, non-alcoholic fatty liver disease and liver stiffness in psoriatic arthritis and psoriasis patients 166
Biomarkers, imaging and disease activity indices in patients with early axial spondyloarthritis: The Italian arm of the SpondyloArthritis-Caught-Early (SPACE) Study 164
Molecular mechanisms of pain in crystal-induced arthritis 163
Are gender-specific approaches needed in diagnosing early axial spondyloarthritis? Data from the SPondyloArthritis Caught Early cohort 161
Squamous cell carcinoma antigen-IgM (SCCA-IgM) is associated with interstitial lung disease in systemic sclerosis 160
Spine and sacroiliac joints on magnetic resonance imaging in patients with early axial spondyloarthritis: Prevalence of lesions and association with clinical and disease activity indices from the italian group of the SPACE study 159
Psoriatic arthritis and obesity: the role of anti-IL-12/IL-23 treatment 159
Infection relapse in spondyloarthritis treated with biological drugs: A single-centre study 155
Severe Abdominal Pain as a Manifestation of Pseudogout in Pubic Symphysis 155
Serological markers in psoriatic arthritis: promising tools 152
IL TREAT-TO-TARGET NELLA REAL-LIFE IN PAZIENTI AFFETTI DA ARTRITE PSORIASICA 150
Effectiveness and safety of ustekinumab in naïve or TNF-inhibitors failure psoriatic arthritis patients: a 24-month prospective multicentric study 148
Effectiveness and safety of secukinumab in axial spondyloarthritis: a 24-month prospective, multicenter real-life study 148
Does gender influence clinical expression and disease outcomes in COVID-19? A systematic review and meta-analysis 147
Mediterranean diet in axial spondyloarthritis: an observational study in an Italian monocentric cohort 142
Work productivity is associated with disease activity and functional ability in Italian patients with early axial spondyloarthritis: An observational study from the SPACE cohort 137
Influence of tumor necrosis factor α inhibitors on testicular function and semen in spondyloarthritis patients 137
Acute joint swelling in psoriatic arthritis: Flare or "psout"-A 10-year-monocentric study on synovial fluid 136
Efficacy and Safety of Ultrasound-Guided Intra-articular Glucocorticoid Injection in Erosive Hand Osteoarthritis 135
An update on serum biomarkers to assess axial spondyloarthritis and to guide treatment decision 135
The prevalence of monosodium urate and calcium pyrophosphate crystals in synovial fluid from wrist and finger joints 134
Subclinical enthesopathy of the midfoot: could it be a peculiar feature in early psoriatic arthritis? 134
Bone edema of the whole vertebral body: an unusual case of spondyloarthritis 133
Effectiveness and safety of secukinumab in 608 patients with psoriatic arthritis in real life: a 24-month prospective, multicentre study 131
The Genetic Contribution to Drug Response in Spondyloarthritis: A Systematic Literature Review 130
Validation of the italian version of the educational needs assessment tool in rheumatoid arthritis patients and factors associated with educational needs 125
Four-year effectiveness, safety and drug retention rate of secukinumab in psoriatic arthritis: a real-life Italian multicenter cohort 124
Do obesity and overweight influence disease activity measures in axial spondyloarthritis? A systematic review and meta-analysis 124
Predictive factors for switching in patients with psoriatic arthritis undergoing anti-TNFα, anti-IL12/23, or anti-IL17 drugs: a 15-year monocentric real-life study 124
Psoriasis and Imaging Progression in early Axial Spondyloarthritis: Results from a 48-month follow-up (Italian arm of SPACE study) 124
Secukinumab Drug Survival in Psoriasis and Psoriatic Arthritis Patients: A 24-Month Real-Life Study 123
Acute joint swelling in psoriatic arthritis: Flare or “psout”—A 10-year-monocentric study on synovial fluid 122
Relationship between sex and clinical and imaging features of early axial spondyloarthritis: results from a 48 month follow-up (Italian arm of the SPondyloArthritis Caught Early (SPACE) study) 121
The impact of diet on disease activity in spondyloarthritis: A systematic literature review 117
Disease and treatment-related morbidity in young and elderly patients with granulomatosis with polyangiitis and microscopic polyangiitis 117
Predictors of disease activity in gout: a 12-month analysis of the ATTACk (Achieving improvement in the management of crystal-induced arthritis) multicentre cohort study 114
Influenza vaccine with adjuvant on disease activity in psoriatic arthritis patients under anti-TNF-α therapy 114
Unusual ossification: psoriatic arthritis or not? 114
The Risk of overdiagnosis and overtreatment in spondyloarthritis 112
ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update 111
Renal involvement at baseline can predict major renal relapse in anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis 111
Long-term effectiveness and drug survival of golimumab in patients affected by psoriatic arthritis with cutaneous involvement 110
Spine and Sacroiliac Joints Lesions on Magnetic Resonance Imaging in Early Axial-Spondyloarthritis During 24-Months Follow-Up (Italian Arm of SPACE Study) 109
Impact of disease duration and gender on the sensitivity and specificity of 2015 ACR/EULAR classification criteria for gout. Cross-sectional results from an Italian multicentric study on the management of crystal-induced arthritis (ATTACk) 106
Do we believe in non-radiographic axial spondyloarthritis? A debate 102
Phenotype of limited cutaneous systemic sclerosis patients with positive anti-topoisomerase I antibodies: data from EUSTAR cohort 100
External validation of the alternative Ankylosing Spondylitis Disease Activity Score in three randomised clinical trials of ixekizumab 98
Subclinical atherosclerosis evolution during 5 years of anti-TNF-alpha treatment in psoriatic arthritis patients. 97
Identification in synovial fluid of a new potential pathogenic player in arthropathies 94
Treat-to-target in real-life psoriatic arthritis patients: achieving minimal disease activity with bDMARDs/tsDMARDs and potential barriers 93
SARS-CoV-2 Infection in Spondyloarthritis Patients Treated With Biotechnological Drugs: A Study on Serology 93
Search for Galactic axions with a high- Q dielectric cavity 85
Answer to Ben Nessib et al. Joint Bone Spine 2023;90:105539 82
Clinical vignette: a rare presentation of a first gout flare 79
Efficacy and safety of non-pharmacological and non-biological interventions: a systematic literature review informing the 2022 update of the ASAS/EULAR recommendations for the management of axial spondyloarthritis 78
Secukinumab Drug Survival in Psoriasis and Psoriatic Arthritis Patients: A 24-Month Real-Life Study 75
Comment on: Development and validation of an alternative ankylosing spondylitis disease activity score when patient global assessment is unavailable: reply 60
Le malattie autoimmuni 57
Development and validation of an alternative ankylosing spondylitis disease activity score when patient global assessment is unavailable 56
Which disease activity outcome measure discriminates best in axial spondyloarthritis? A systematic literature review and meta-analysis 53
Efficacy and safety of biological DMARDs: a systematic literature review informing the 2022 update of the ASAS-EULAR recommendations for the management of axial spondyloarthritis 38
null 3
Totale 9.113
Salva come PNG Salva come JPEG
Categoria #
all - tutte 31.678
article - articoli 31.207
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 173
Totale 63.058
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021582 0 0 0 0 8 39 15 54 65 85 73 243
2021/2022837 32 106 42 63 17 77 55 82 22 53 58 230
2022/2023587 143 72 17 65 80 52 3 37 55 13 17 33
2023/2024527 10 47 54 60 33 62 40 53 37 28 43 60
2024/20251.845 6 155 73 89 205 64 98 213 114 102 285 441
2025/20263.526 415 498 964 1.234 415 0 0 0 0 0 0 0
Totale 9.113